NL-OMON23571招募中不适用
Muticentre study to investigate the efficacy of scalp cooling for the prevention of Myocet/cyclofosfamideinducedalopecia in patients with metastatic breast cancer. MyCap study.
Stichting DIADOC0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Female breast cancer patients, treated with Myocet and cyclophosphamide containing chemotherapy;
- •2. Life expectancy >=12 weeks;
排除标准
- •1. Allopecia prior to start of the study;
- •2. Simultaneously or shortly after study start: planned skull irradiation (if allopecia is expected);
研究者
相似试验
已完成
不适用
Muticentre study to investigate the efficacy of scalp cooling for the prevention of Myocet/cyclofosfamide-induced alopecia in patients with metastatic breast cancer. MyCap studyhaaruitval t.g.v. chemotherapiehair lossalopeciaNL-OMON35380Stichting DIADOC70
已完成
不适用
A multi centre study to determine the efficacy and patient acceptability of scalp cooling in the prevention of docetaxel-induced hair loss.Hair lossNL-OMON26657eids Universitair Medisch Centrum in Leiden260
进行中（未招募）
不适用
A study conducted at several study sites with a human growth hormone in a liquid form and a concentration of 3.3. mg/mL that is produced by using genetic engineering techniques, to find out more about how efficacious it works and how safe its use is in pre-pubertal children of small stature who’s bodies do not produce sufficient amounts of own growth hormone.Small stature secondary to growth hormone insufficiency deficiencyEUCTR2015-002802-34-Outside-EU/EEASandoz SAS100
进行中（未招募）
不适用
A Multicenter Study Evaluating the Efficacy and Safety of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Headache Prophylaxis in Migraine Patients with 15 or More Headache Days per 4-Week Period in a 24-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase Followed by a 32-Week Open-Label Extension PhaseEUCTR2005-004637-17-DEALLERGAN LTD650
进行中（未招募）
1 期
A Multicenter Study Evaluating the Efficacy and Safety of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Headache Prophylaxis in Migraine Patients with 15 or More Headache Days per 4-Week Period in a 24-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase Followed by a 32-Week Open-Label Extension PhaseEUCTR2005-004637-17-GBALLERGAN LTD650